Peak Pharmaceuticals Develops Market Entry Strategy
Peak Pharmaceuticals Inc. (OTCQB:CTCO) announced that it has completed an analysis of the human and veterinary supplement markets, and based on its research has put together a three-year market entry strategy.
As quoted in the press release:
Working under the auspices of the 2014 Executive Multidisciplinary Action Program at the Stephen M. Ross School of Business at the University of Michigan, two teams of Executive MBA (EMBA) students were engaged in September, 2014 to carry out a three month project in close collaboration with Peak Pharmaceuticals as industry partner. The research included a detailed analysis of the nutraceutical sector and preparation of three-year market entry strategies for hemp-based products targeting human and animal health channel markets.
The project scope included assessment and situational analysis of the target market domains including customer segments and channels, an in depth study of the competitive landscape, and a strategy for aggressively entering these markets.
Both EMBA teams delivered their final reports in December, including executive summaries, as well as base case product launch strategies along with a detailed analysis of the company, competitors, customers, collaborators and context (5C’s) across the U.S. nutraceutical/medical hemp market. Additional details included an analysis of segmentation, targeting and positioning, pricing policies, route to market and gaps within current strategies.
The deliverables further included (where applicable) survey results of key interviewees from relevant industries and consumer groups, and culminated with a 3-year plan for proposed activities with potential extended “blue sky” strategies.